00000nam 2200000zi 4500 9.894118 CaOODSP 20230925103305 m o d f cr cn||||||||| 201127t20212019onc o f000 0 eng d 9780660367620 CaOODSP eng rda CaOODSP n-cn--- H164-305/2021E-PDF Guidance document : certificates of supplementary protection. Certificates of supplementary protection CSP guidance document Ottawa, ON : Health Canada = Santé Canada, 2021. ©2019 1 online resource (25 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover title. Issued also in HTML format. "Effective date: 2021/01/06." Issued also in French under title: Ligne directrice : certificats de protection supplémentaire. "In agreeing to provisionally apply the Canada-European Union Comprehensive Economic and Trade Agreement (CETA), Canada has committed to provide up to two years of sui generis protection for new pharmaceutical products protected by an eligible patent, from the expiry of the patent. Canada has implemented this commitment by introducing Certificates of Supplementary Protection (CSPs) for medicinal ingredients, applicable for Canadian pharmaceuticals, biologics and veterinary drugs"--Introduction, page 7. Patent medicines Canada. Patent extensions Canada. Pharmaceutical policy Canada. Canada. Health Canada, issuing body. Ligne directrice : (CaOODSP)9.894119 Guidance document : (CaOODSP)9.921627 PDF 337 KB https://publications.gc.ca/collections/collection_2021/sc-hc/H164-305-2021-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/register-certificates/certificate-supplementary-protection-regulations.html 200313